Tci Wealth Advisors, Inc. Avidity Biosciences, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$15.35 - $25.65 $2,885 - $4,822	188 New	188 $2,000
Q1 2022 Apr 29, 2022	SELL	$14.2 - $23.78 $2,257 - $3,781	-159 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$20.4 - $28.66 $2,652 - $3,725	-130 Reduced 44.98%	159 $4,000
Q3 2021 Oct 29, 2021	BUY	$18.16 - $25.21 $2,887 - $4,008	159 Added 122.31%	289 $7,000
Q1 2021 Apr 29, 2021	BUY	$20.28 - $28.15 $2,636 - $3,659	130 New	130 $3,000

256

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.25B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.